ȨÀ¸·Î
·Î±×ÀÎ
ȨÆäÀÌÁö ȸ¿ø°¡ÀÔ
ENGLISH
÷´ÜÀç»ýÀÇ·á»ê¾÷Çùȸ ¹Ù·Î°¡±â
Çùȸ¼Ò°³
Àλ縻
¼³¸³ÃëÁö/¿¬Çõ
Á¶Á÷µµ
ÁÖ¿äȰµ¿
ã¾Æ¿À½Ã´Â ±æ
ȸ¿ø»ç
ȸ¿øÇöȲ
ȸ¿ø°¡ÀÔ
ȸ¿ø»ç¼Ò½Ä
Ȱµ¿¼Ò½Ä
Çà»çÀÏÁ¤
GALLERY
À§¿øÈ¸ Ȱµ¿
±âºÎ¾È³»
±âºÎ¾È³»
±âºÎÀÚ ¼Ò°³
±âºÎ±Ý »ç¿ë ³»¿ª
¾Ë¸²¸¶´ç
°øÁö»çÇ×
¾ð·Ðº¸µµ
¹ßÇ๰
ÀÚ·á½Ç
¸Þ´º´Ý±â
ȨÀ¸·Î
·Î±×ÀÎ
ȨÆäÀÌÁö ȸ¿ø°¡ÀÔ
Çùȸ ¼Ò°³
ȸ¿ø»ç
Çà»ç¾È³»
±âºÎ¾È³»
¾Ë¸²¸¶´ç
Àλ縻
¼³¸³ÃëÁö/¿¬Çõ
ÁÖ¿äȰµ¿
Á¶Á÷µµ
ã¾Æ¿À½Ã´Â ±æ
ȸ¿øÇöȲ
ȸ¿ø°¡ÀÔ
ȸ¿ø»ç¼Ò½Ä
Çà»çÀÏÁ¤
GALLERY
À§¿øÈ¸ Ȱµ¿
±âºÎ¾È³»
±âºÎÀÚ ¼Ò°³
±âºÎ±Ý »ç¿ë ³»¿ª
°øÁö»çÇ×
¾ð·Ðº¸µµ
¹ßÇ๰
ÀÚ·á½Ç
¾Ë¸²¸¶´ç
°øÁö»çÇ×
°øÁö»çÇ×
¾ð·Ðº¸µµ
¹ßÇ๰
ÀÚ·á½Ç
°øÁö»çÇ×
¾ð·Ðº¸µµ
¹ßÇ๰
ÀÚ·á½Ç
°øÁö»çÇ×
Ȩ ¹Ù·Î°¡±â
¾Ë¸²¸¶´ç
°øÁö»çÇ×
¹øÈ£
Á¦¸ñ
ÀÛ¼ºÀÚ
µî·ÏÀÏ
Á¶È¸¼ö
÷ºÎ
[°øÁö]
÷´ÜÀç»ýÀÇ·á»ê¾÷Çùȸ °øÀ͹ýÀÎ ÀçÁöÁ¤ ¾Ë¸²
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2026-04-17
Á¶È¸¼ö
611
[°øÁö]
2026³â CELL-UP ±ÔÁ¦Áö¿ø»ç¾÷ ͏°´õ
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2026-01-02
Á¶È¸¼ö
1824
[°øÁö]
÷´ÜÀç»ýÀÇ·á»ê¾÷Çùȸ(CARM) ´º½º·¹ÅÍ
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2022-05-04
Á¶È¸¼ö
1717
[°øÁö]
¿¬È¸ºñ ³³ºÎ ¹æ½Ä º¯°æ ¾È³» (Àç)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2022-03-03
Á¶È¸¼ö
1575
323
[À¯°ü±â°ü/KTR] À¯ÀüÀÚÄ¡·áÁ¦ »ý»ê °íµµÈ¸¦ À§ÇÑ °ø°ø CDMO ¹× ¿ø½ºÅé Ç÷§Æû ±¸Ãà ¼ö¿äÁ¶»ç ¾È³» (~3/20)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-14
Á¶È¸¼ö
731
322
[À¯°ü±â°ü/Çѱ¹»ê¾÷±â¼ú±âȹÆò°¡¿ø] ÷´Ü¹ÙÀÌ¿ÀÀǾàǰ ºÐ¾ß ±â¾÷ ÅõÀÚ °èȹ Á¶»ç ÇùÁ¶¿äû (~3/8 15:00)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-06
Á¶È¸¼ö
167
÷ºÎÆÄÀÏ
321
[ȸ¿ø»ç/Áø½ºÅ©¸³Æ® ÇÁ·Î¹ÙÀÌ¿À] Cell Therapy Development Strategies to Expand Patient Access ¿þºñ³ª °³ÃÖ ¾È³» (3/28)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-03-06
Á¶È¸¼ö
139
÷ºÎÆÄÀÏ
320
[À¯°üÇà»ç/informa connect] BioProcess International US West °³ÃÖ ¹× »çÀüµî·Ï ¾È³» (3/11-14 PST)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-22
Á¶È¸¼ö
159
÷ºÎÆÄÀÏ
319
[½Ä¾àó] 2024³â ¹ÙÀÌ¿ÀÀǾàǰ Çã°¡¤ý½É»ç ¿ª·® °È ¼³¸íȸ(BioUpdate) °³ÃÖ ¾È³» (3/11)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-19
Á¶È¸¼ö
188
÷ºÎÆÄÀÏ
318
ÇູÇÑ ¼³ ¸íÀý º¸³»½Ã±â ¹Ù¶ø´Ï´Ù.
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-08
Á¶È¸¼ö
145
317
[À¯°ü±â°ü/KFRM] 2024³âµµ ¹üºÎóÀç»ýÀÇ·á±â¼ú°³¹ß»ç¾÷ ½Å±ÔÁö¿ø ´ë»ó°úÁ¦ °ø°í(³»¿ª»ç¾÷ 3) (~2/28)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-08
Á¶È¸¼ö
178
÷ºÎÆÄÀÏ
316
[½Ä¾àó] ÷´Ü¹ÙÀÌ¿ÀÀǾàǰ ½ÃÆÇ ÈÄ Ç°ÁúÆò°¡¸¦ À§ÇÑ °í·Á»çÇ×[¹Î¿øÀÎ ¾È³»¼] ¹ß°£ ¾È³»
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-07
Á¶È¸¼ö
174
÷ºÎÆÄÀÏ
315
[ÃæÃ»ºÏµµ] ÷´Ü´ëü½ÃÇè¹ý »êÇп¬°ü Á¤º¸±³·ù ½ÉÆ÷Áö¾ö °³ÃÖ ¾È³» (2/7)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-02-06
Á¶È¸¼ö
142
÷ºÎÆÄÀÏ
314
[À¯°ü±â°ü/°úÇбâ¼úÀü·«¿¬±¸¼Ò] ÷´Ü¹ÙÀÌ¿À Ä¡·áÁ¦ ¸ÂÃãÇü Á¦Á¶°øÁ¤ Çõ½Å»ç¾÷ - ¹Î°£±â¾÷ Âü¿©ÀÇÇâ Á¶»ç ¾È³» (~2/9 12:00)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-01-29
Á¶È¸¼ö
193
÷ºÎÆÄÀÏ
313
[ÃæÃ»ºÏµµ] 2024 ¡¸ÃæºÏ ÷´ÜÀç»ý¹ÙÀÌ¿À ±Û·Î¹ú Çõ½Å Ư±¸¡¹ »ç¾÷¼³¸íȸ °³ÃÖ ¾È³» (1/19)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-01-17
Á¶È¸¼ö
224
÷ºÎÆÄÀÏ
312
[À¯°ü±â°ü/RMAF] ÷´ÜÀç»ýÀÇ·á ½Ç½À±³À°À» À§ÇÑ GMP ½Ã¼³ Á¦°ø °¡´É ±â¾÷ Á¶»ç (~1/23)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-01-16
Á¶È¸¼ö
188
÷ºÎÆÄÀÏ
311
[À¯°ü±â°ü/KFRM] 2024³âµµ ¹üºÎóÀç»ýÀÇ·á±â¼ú°³¹ß»ç¾÷ ½Å±ÔÁö¿ø ´ë»ó°úÁ¦ °ø°í ¾È³» (~1/23)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2024-01-15
Á¶È¸¼ö
162
÷ºÎÆÄÀÏ
310
[½Ä¾àó] ¡¸¼¼Æ÷¿Ü¼ÒÆ÷Ä¡·áÁ¦ ǰÁú, ºñÀÓ»ó ¹× ÀÓ»ó Æò°¡ °¡À̵å¶óÀÎ(¹Î¿øÀÎ ¾È³»¼)¡¹ °³Á¤ ¾Ë¸²
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2023-12-28
Á¶È¸¼ö
162
÷ºÎÆÄÀÏ
309
Çѱ¹Á¦¾à¹ÙÀÌ¿ÀÇコÄɾÇÕȸ Á¦6Â÷ Æ÷·³ °³ÃÖ ¾È³» (1/11 10:00)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2023-12-27
Á¶È¸¼ö
176
308
[ȸ¿ø»ç/½á¸ðÇǼŻçÀ̾ðƼÇÈ] ¿Â¶óÀÎ ±³À° Ç÷§Æû Edu Center ¿ÀÇ ¹× °ü·Ã À̺¥Æ® ¾È³»
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2023-12-26
Á¶È¸¼ö
127
÷ºÎÆÄÀÏ
307
[ȸ¿ø»ç/Áø½ºÅ©¸³Æ® ÇÁ·Î¹ÙÀÌ¿À] Genscript Biotech Global Forum 2024 °³ÃÖ ¾È³»
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2023-12-07
Á¶È¸¼ö
185
÷ºÎÆÄÀÏ
306
[ȸ¿ø»ç/½á¸ðÇǼŻçÀ̾ðƼÇÈ] Key Account manager (¼ö¼®±Þ) ä¿ë °ø°í
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2023-12-05
Á¶È¸¼ö
167
305
[À¯°ü±â°ü/RMAF] 2023³â Á¦2Â÷ ÷´ÜÀç»ýÀÇ·á Àӻ󿬱¸Æ÷·³ °³ÃÖ ¹× »çÀüµî·Ï ¾È³» (~12/8)
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2023-11-27
Á¶È¸¼ö
166
304
[½Ä¾àó] ¡¸Çö󽺹̵å DNA ±â¹Ý Ä¡·áÁ¦ÀÇ Ç°Áú ¹× ºñÀÓ»ó½ÃÇè Æò°¡ °¡À̵å¶óÀÎ (¹Î¿øÀÎ ¾È³»¼)¡¹ °³Á¤ ¾Ë¸²
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
µî·ÏÀÏ
2023-11-27
Á¶È¸¼ö
155
÷ºÎÆÄÀÏ
11
12
13
14
15
Á¦ ¸ñ
³» ¿ë
Á¦¸ñ + ³»¿ë
ÀÛ¼ºÀÚ
¾ÆÀ̵ð
°Ë»ö